International collaboration on childhood leukemia

被引:39
作者
Pui, CH
Ribeiro, RC
机构
[1] St Jude Childrens Res Hosp, Dept Hematol Oncol, Memphis, TN 38105 USA
[2] St Jude Childrens Res Hosp, Int Outreach Program, Memphis, TN 38105 USA
[3] Univ Tennessee, Ctr Hlth Sci, Coll Med, Memphis, TN 38163 USA
关键词
leukemia; childhood leukemia; acute lymphoblastic leukemia; cure;
D O I
10.1007/BF02983810
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The current cure rate of childhood acute lymphoblastic leukemia has reached 80% in many industrialized countries, but in developing countries the rate is often less than 10%. To advance the cure rate, investigators have formed several parallel initiatives in both industrialized and developing countries through international collaboration and partnership. Among industrialized countries. investigators have combined data to conduct in-depth studies of the biology and heterogeneity of high-risk or drug-resistant subgroups of leukemia to identify optimal or novel treatments. Alliances have been established among government, local nongovernmental organizations, health care providers, and international groups to improve the survival rate of childhood leukemia in developing countries. "Twinning" partnerships between a well-established individual institution or study group and a pediatric cancer unit in a developing country has proved to be the most successful strategy to date. Int J Hematol. 2003;78:383-389. (C) 2003 The Japanese Society of Hematology.
引用
收藏
页码:383 / 389
页数:7
相关论文
共 64 条
[1]  
Agarwal B., 2003, CONTEMPORARY CLIN NE, P321
[3]   Outcome of treatment in children with philadelphia chromosome-positive acute lymphoblastic leukemia [J].
Aricò, M ;
Valsecchi, MG ;
Camitta, B ;
Schrappe, M ;
Chessells, J ;
Baruchel, A ;
Gaynon, P ;
Silverman, L ;
Janka-Schaub, G ;
Kamps, W ;
Pui, CH ;
Masera, G .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (14) :998-1006
[4]   MLL translocations specify a distinct gene expression profile that distinguishes a unique leukemia [J].
Armstrong, SA ;
Staunton, JE ;
Silverman, LB ;
Pieters, R ;
de Boer, ML ;
Minden, MD ;
Sallan, SE ;
Lander, ES ;
Golub, TR ;
Korsmeyer, SJ .
NATURE GENETICS, 2002, 30 (01) :41-47
[5]  
Barr RD, 1996, INT J ONCOL, V8, P933
[6]  
BARR RD, 1994, E AFR MED J, V71, P223
[7]  
Barr RD., 2002, PRINCIPLES PRACTICE, V1541, P1552
[8]   Acute lymphoblastic leukemia in a developing country:: Preliminary results of a nonrandomized clinical trial in El Salvador [J].
Bonilla, M ;
Moreno, N ;
Marina, N ;
deReyes, G ;
Shurtleff, SA ;
Downing, JR ;
Behm, FG ;
Harrison, PL ;
Ribeiro, RC ;
Peña, O ;
Crist, WM ;
Antillon, FG .
JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2000, 22 (06) :495-501
[9]  
CARDENAS F, 2001, MED PEDIATR ONCOL, V36, P307
[10]   CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA IN INDIA - AN APPROACH TO MANAGEMENT IN A 3-TIER SOCIETY [J].
CHANDY, M .
MEDICAL AND PEDIATRIC ONCOLOGY, 1995, 25 (03) :197-203